1.Y-graft Replacement for Ruptured of Abdominal Aortic Aneurysm in an Elderly Patient
Takashi Ogino ; Tatsuo Kaneko ; Yasushi Satoh ; Masahiko Ezure ; Yutaka Hasegawa ; Hirotaka Inaba ; Toshiharu Yamagishi ; Shigeru Ohki ; Yasuo Morishita
Japanese Journal of Cardiovascular Surgery 2003;32(5):322-324
Y-graft replacement was successfully performed in a patient aged 93 years with ruptured infrarenal abdominal aortic aneurysm. The patient was in shock on arrival and underwent an emergency operation with the administration of cathecholamines. The ruptured infrarenal abdominal aortic aneurysm with a large hematoma, which was located in the area of the left common iliac artery, was 10cm in the maximum diameter. The bilateral common iliac arteries were strongly calcified and occluded. The distal end of the graft was anastomosed to the external iliac artery. The patient's postoperative course was uneventful.
2.Fluoropyrimidines S-1 and Capecitabine may Prolong International Normalized Ratios of Prothrombin Time by 3-Fold in Cancer Patients Receiving Warfarin
Masayuki Ikenishi ; Akiko Kuroda ; Haruhiko Tsukazaki ; Masahiko Nakao ; Masashi Takeuchi ; Yuji Konishi ; Toshiyuki Matsuda ; Tohru Ohtori ; Kenji Matsuyama ; Mitsutaka Takada ; Hiroki Satoh ; Yasufumi Sawada ; Mutsuaki Ueda
Japanese Journal of Drug Informatics 2016;18(3):172-178
Objective: To compare effects of the fluoropyrimidines S-1 and capecitabine on prothrombin time international normalized ratios (PT-INR) of warfarin following coadministration and after discontinuation of each fluoropyrimidine treatment.
Methods: Medical records of patients receiving warfarin with either S-1 (6 patients) or capecitabine (7 patients) were obtained from four hospitals.
Results: Increased PT-INR was observed until peak levels of warfarin were achieved in all patients in S-1 and capecitabine treatment groups. Moreover, PT-INR significantly changed after coadministration within each group (p<0.05). Specifically, ratios of peak PT-INR after coadministration of each fluoropyrimidine and those following administration of warfarin alone (PT-INR elevation ratio) were 3.31 and 3.29 in S-1 and capecitabine coadministration groups, respectively. Moreover, numbers of days to peak PT-INR were 38.3 and 31.3 days, respectively, and did not significantly differ between the treatment groups. Furthermore, PT-INR returned to pretreatment levels by 17.5 and 15.1 days after discontinuation of S-1 and capecitabine, respectively, and did not significantly differ between the treatment groups.
Conclusion: Coadministration of S-1 and capecitabine similarly prolongs PT-INR by approximately 3-fold compared with administration of warfarin alone; therefore, these drug-drug interactions were clinically suggested to be of high risk for episodes of bleeding and remarkable alterations in coagulation parameters. Therefore, blood coagulation ability should be more carefully monitored with regard to PT-INRs in patients receiving warfarin with S-1 or capecitabine not only during coadministration but also after discontinuation of fluoropyrimidine treatments.
3.Methylmercury toxic mechanism related to protein degradation and chemokine transcription.
Jin-Yong LEE ; Gi-Wook HWANG ; Akira NAGANUMA ; Masahiko SATOH
Environmental Health and Preventive Medicine 2020;25(1):30-30
Methylmercury is an environmental pollutant that causes neurotoxicity. Recent studies have reported that the ubiquitin-proteasome system is involved in defense against methylmercury toxicity through the degradation of proteins synthesizing the pyruvate. Mitochondrial accumulation of pyruvate can enhance methylmercury toxicity. In addition, methylmercury exposure induces several immune-related chemokines, specifically in the brain, and may cause neurotoxicity. This summary highlights several molecular mechanisms of methylmercury-induced neurotoxicity.
Animals
;
Chemokines
;
drug effects
;
metabolism
;
Humans
;
Methylmercury Compounds
;
toxicity
;
Mice
;
Neurotoxins
;
toxicity
;
Proteolysis
;
drug effects
;
Rats
;
Saccharomyces cerevisiae
;
drug effects
4.Socioeconomic and lifestyle factors associated with depressive tendencies in general Japanese men and women: NIPPON DATA2010.
Harumitsu SUZUKI ; Aya KADOTA ; Nagako OKUDA ; Takehito HAYAKAWA ; Nobuo NISHI ; Yasuyuki NAKAMURA ; Hisatomi ARIMA ; Naoko MIYAGAWA ; Atsushi SATOH ; Naomi MIYAMATSU ; Masahiko YANAGITA ; Hiroshi YATSUYA ; Zentaro YAMAGATA ; Takayoshi OHKUBO ; Tomonori OKAMURA ; Hirotsugu UESHIMA ; Akira OKAYAMA ; Katsuyuki MIURA ; NIPPON DATA2010 Research Group
Environmental Health and Preventive Medicine 2019;24(1):37-37
BACKGROUND:
The gender-specific characteristics of individuals at an increased risk of developing depression currently remain unclear despite a higher prevalence of depression in women than in men. This study clarified socioeconomic and lifestyle factors associated with an increased risk of subclinical depression in general Japanese men and women.
METHODS:
Study participants were residents not receiving psychiatric treatments in 300 sites throughout Japan in 2010 (1152 men, 1529 women). Multivariable-adjusted odds ratios (OR) and 95% confidence intervals (95%CIs) for socioeconomic factors and lifestyle factors were calculated using a logistic regression analysis.
RESULTS:
Risk of depressive tendencies was significantly higher in men who were single and living alone (OR, 3.27; 95% CI, 1.56-6.88) than those married. The risk was significantly lower in women who were not working and aged ≥ 60 years (OR, 0.39; 95% CI, 0.22-0.68) and higher in men who were not working and aged < 60 years (OR, 3.57; 95%CI, 1.31-9.72) compared with those who were working. Current smoking was also associated with a significantly increased risk of depressive tendencies in women (OR, 2.96; 95% CI, 1.68-5.22) but not in men.
CONCLUSIONS
Socioeconomic and lifestyle factors were associated with an increased risk of depressive tendencies in general Japanese. Related factors were different by sex.
Adult
;
Aged
;
Community Psychiatry
;
statistics & numerical data
;
trends
;
Depression
;
epidemiology
;
Female
;
Health Surveys
;
Humans
;
Japan
;
epidemiology
;
Life Style
;
Male
;
Middle Aged
;
Odds Ratio
;
Prevalence
;
Risk Factors
;
Socioeconomic Factors